Matrine inhibits BCR/ABL mediated ERK/MAPK pathway in human leukemia cells.

Matrine inhibits BCR/ABL mediated ERK/MAPK pathway in human leukemia cells.
复制标题

苦参碱抑制人白血病细胞中 BCR/ABL 介导的 ERK/MAPK 通路

DOI:
10.18632/oncotarget.22353
复制
发表时间:
2017-12-12
期刊:
影响因子:
--
通讯作者:
Zou C
Zou C
中科院分区:
其他
文献类型:
--
作者:
Ma L;Xu Z;Wang J;Zhu Z;Lin G;Jiang L;Lu X;Zou C

文献摘要

参考文献

被引文献

相似文献

Bcr/abl融合基因及其下游信号通路如RAS/Raf/MAPK、JAK/STAT3、PI3K/AKT在白血病尤其是慢性粒细胞白血病(CML)的恶性转化中起重要作用。我们前期的研究表明,苦参碱可显著抑制人慢性粒细胞白血病K562细胞的增殖,诱导细胞周期停滞于G0/G1期,并促进细胞凋亡。在本研究中,我们利用K562和HL-60细胞株研究了苦参碱抑制白血病细胞生长的分子机制。RT-PCR和Western印迹分析表明,苦参碱可显著抑制K562和HL-60细胞bcr/abl基因的表达。MEK1、ERK1/2及其上游接头分子Shc和SHP2的磷酸化水平显著下调。ERK/MAPK信号通路各组成部分以及Bclxl、Cyclin D1和c-Myc的蛋白和mRNA表达显著降低。相反,苦参碱处理后,细胞周期进程的负调控因子p27的表达增加。以上结果提示,苦参碱抑制K562和HL-60细胞生长与抑制ERK/MAPK和BCR/ABL信号通路有关。在体内实验中,苦参碱显著降低荷瘤小鼠的死亡率,提示苦参碱在体内具有抗白血病作用。
The BCR/ABL fusion gene and its downstream signaling pathways such as Ras/Raf/MAPK, JAK/STAT3, and PI3K/AKT pathways play important roles in malignant transformation of leukemia, especially chronic myelogenous leukemia (CML). Our previous study showed that matrine, an alkaloid extracted from a Chinese herb radix sophorae, significantly inhibited the proliferation of human CML K562cells, induced cell cycle arrest in G0/G1, and promoted cell apoptosis. In the present study, we investigated the molecular mechanism of matrine in the growth inhibition of leukemia cells using K562 and HL-60 cell lines. RT-PCR and Western blot assay demonstrated that the expression of BCR/ABL in K562 and HL-60 cells was significantly inhibited by matrine treatment. Phosphorylation of MEK1, ERK1/2, and their upstream adaptor molecules Shc and SHP2 were significantly downregulated. The protein and mRNA expression of components of the ERK/MAPK signal pathway, and Bcl-xL, Cyclin D1, and c-Myc, were dramatically reduced. Conversely, the expression of p27, a negative regulator of cell cycle progression, increased after matrine treatment. These results indicated that the inhibition of ERK/MAPK and BCR/ABL signaling pathway was associated with matrine’s suppressive effects on the growth of K562 and HL-60 cells. In in vivo study, matrine significantly decreased the mortality rate of tumor-baring mice and suggested that matrine could exert its anti-leukemia effect in vivo.
DOI: 10.1038/leu.2010.257
发表时间: 2011-02
期刊: Leukemia
影响因子: 11.4
作者:
通讯作者: --
DOI: 10.1056/nejmoa062867
发表时间: 2006-12-07
影响因子: 158.5
作者:
Druker, Brian J.;Guilhot, Francois;Larson, Richard A.
通讯作者: Larson, Richard A.
DOI: 10.3892/ijo.2011.1062
发表时间: 2011-09-01
影响因子: 5.2
作者:
Hentschel, Julia;Rubio, Ignacio;Von Eggeling, Ferdinand
通讯作者: Von Eggeling, Ferdinand
DOI: 10.1158/0008-5472.can-03-1484
发表时间: 2004-01-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Donato, NJ;Wu, JY;Talpaz, M
通讯作者: Talpaz, M
DOI: 10.1142/s0192415x06004557
发表时间: 2006-01-01
影响因子: 5.7
作者:
Liu, Xiao-Shan;Jiang, Jikai
通讯作者: Jiang, Jikai